CARB-X
Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.
CARB-X
Founded:
2016-07-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Wordpress Plugins Global Site Tag Nginx
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Richard Alm Chief Scientific Officer @ CARB-X
Chief Scientific Officer
2021-10-01
Kevin Outterson Executive Director @ CARB-X
Executive Director
Diane MacDonald Chief Operating Officer @ CARB-X
Chief Operating Officer
2018-01-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-04 | Clarametyx Biosciences | CARB-X investment in Grant - Clarametyx Biosciences | 3.89 M USD |
| 2021-08-05 | Vaxcyte | CARB-X investment in Grant - Vaxcyte | 3.2 M USD |
| 2021-06-08 | Accelerate Diagnostics | CARB-X investment in Grant - Accelerate Diagnostics | 578 K USD |
| 2021-06-01 | BioVersys | CARB-X investment in Grant - BioVersys | 4.35 M USD |
| 2021-05-27 | SNIPR Biome | CARB-X investment in Grant - SNIPR Biome | 10.2 M USD |
| 2021-05-19 | Basilea Pharmaceutica | CARB-X investment in Grant - Basilea Pharmaceutica | 2.7 M USD |
| 2021-05-18 | Summit Therapeutics | CARB-X investment in Grant - Summit Therapeutics | 4.1 M USD |
| 2021-05-10 | SpeeDx | CARB-X investment in Grant - SpeeDx | 1.8 M USD |
| 2021-04-27 | GenomeKey | CARB-X investment in Grant - GenomeKey | 9.5 M USD |
| 2021-04-20 | Baebies | CARB-X investment in Grant - Baebies | 11.6 M USD |
More informations about "CARB-X"
Overview - Carb-X
The CARB-X portfolio is the world’s most scientifically diverse, early development pipeline of new antibiotics, preventatives, rapid diagnostics and other …See details»
CARB-X launches new funding round to fill major R&D gaps in …
Mar 6, 2024 CARB-X is funded in part with federal funds from the U.S. Department of Health and Human Services (HHS); Administration for Strategic Preparedness and Response; Biomedical …See details»
CARB-X - Wikipedia
Bacteria are constantly evolving to evade death. Even the most powerful "last resort" drugs are becoming less effective due to resistance. Without an arsenal of effective antibiotics to treat infections, modern medical procedures – such as chemotherapy and surgeries – are more risky and put patients' lives at risk. Approximately 1.27 million people died globally in 2019 due to drug-resistant bacterial infections. CARB-X supports projects that are focused on the most dangerou…See details»
Combating Antibiotic-Resistant Bacteria Biopharmaceutical …
May 15, 2020 CARB-X is funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and …See details»
CARB-X key features - innovationacta.eu
• CARB-X is the only global partnership that integrates solutions for the prevention, diagnosis and treatment of life-threatening bacterial infections, translating innovation from basic research to …See details»
CARB-X announces new round of funding for …
Feb 26, 2025 CARB-X says applicants from around the world, particularly countries in which the AMR burden is high, are encouraged to apply. Proposals can be submitted from April 16 through April 30. Since 2016, CARB-X has …See details»
CARB-X Funds 100th Project—a Milestone for BU …
Mar 6, 2024 The World Health Organization has flagged the resistance of bacteria like Klebsiella pneumoniae to antibiotics as a major concern. BU-based CARB-X, which just funded its 100th project, aims to accelerate the …See details»
CARB-X - Institute for Life Science Entrepreneurship
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is one of the largest and most promising global non-profit partnerships addressing AMR by supporting the development of new antibiotics and other life-saving …See details»
Our Strategy - Carb-X
While CARB-X grants are non-dilutive, we require our product developers to have solid assets that have demonstrated private investment in their project. The result is an innovative pipeline that is growing. Since 2017, the year of our first …See details»
Government of Canada makes important investment to fight …
May 11, 2023 CARB-X is a non-profit organization and global partnership working to address the threat of antibiotic resistance. Today, the Honourable Jean-Yves Duclos, Minister of Health, …See details»
CARB-X - Crunchbase Investor Profile & Investments
Find More Contacts for CARB-X. Protected Content. Chief Scientific Officer. Non-Management, Executive Medical & Science 1 email found 1 phone number found . View contacts for CARB …See details»
CARB-X Collaborative Hub for Early Antibiotic Discovery
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global initiative dedicated to protecting humankind from the most serious bacterial threats to human …See details»
Combating Antibiotic-Resistant Bacteria Biopharmaceutical ... - NIRO
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global not-for-profit partnership led by Boston University and funded by a consortium of governments …See details»
CARB-X Receives Global Funding in Fight Against Antimicrobial ...
Aug 23, 2023 Since its founding in 2016, Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has served as a global non-profit partnership …See details»
CARB-X launches 2025 Funding Round targeting global infectious …
CARB-X is funded in part with federal funds from the U.S. Department of Health and Human Services (HHS); Administration for Strategic Preparedness and Response; Biomedical …See details»
Apply Here - Carb-X
The 2025 Funding Round will be open from 16 April 2025 at 10:00 ET – 30 April 2025 at 23:59 ET. Please review the funding themes to learn if your project is in scope.. Please sign up for …See details»
Inside CARB-X: can this new model for research fix a broken …
Nov 22, 2017 CARB-X was founded last year, in response to the US Government’s 2015 Combating Antibiotic Resistant Bacteria initiative, with the goal of fixing this market failure. …See details»
Homemade Sugar Free Low Carb Keto Beef Jerky Recipe
56 minutes ago She has been Sugar Free & Refined carb free for 17 years and has written 2 cookbooks, Sugar-Free Mom, and Naturally Keto and her 3rd book The 30-Day Sugar …See details»
CARB-X funds Immunethep to develop vaccine to prevent E. coli ...
CARB-X Contact: Marissa Novel, carbxpr@bu.edu. Immunethep Contact: info@immunethep.com. About CARB-X. CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical …See details»
Government of Canada to join CARB-X partnership
Aug 3, 2023 $6.3 million committed in support of global and Canadian antibacterial innovation (BOSTON: August 3, 2023) – In advance of the G7 Health Ministers’ Meeting in Nagasaki, the …See details»